4Nahajevszky S, Kapas B, Adam E, et al. Prognostic significance of age and karyotype in the treatment of acute myeloid leukemia: results at our center. Orv Hetil, 2004 ; 145: 167 - 172
5Giles FJ, Shen Y, Kantarjian HM, et al. Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long term survival. Leuk Lymphoma, 2001 ; 42:67 -73
7Estey EH, Shen Y,Thall PF. Effect of time to complete remission on subsequent survival and disease-free survival time in AML, RAEB-t and RAEB. Blood, 2000; 95:72 -77
8Champlin R, Jacobs A, Gale RP, et al. Prolonged survival in acute myelogenous leukemia without maintenance chemotherapy. Lancet, 1984; 1 (8382):894-896
9Uhlman DL, Bloomfield CD, Hurd DD, et al. Prognostic factors at relapse for adults with acute myeloid Leukemia. Am J Hematol, 1990;33:110 - 116
10Leopold LH, Willemze R. The treatment of acute myeloid leukemia in first relapse:a comprehensive review of the literature. Leuk Lymphoma, 2002 ; 43 : 1715 - 1727
